Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Rises By 274.3%

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 61,662 shares, a growth of 274.3% from the June 30th total of 16,476 shares. Based on an average trading volume of 256,414 shares, the short-interest ratio is presently 0.2 days. Currently, 12.1% of the company’s stock are sold short.

Autonomix Medical Price Performance

Shares of NASDAQ:AMIX opened at $2.79 on Tuesday. The company has a market capitalization of $1.51 million, a PE ratio of -0.04 and a beta of -1.32. The business has a fifty day moving average price of $6.87 and a two-hundred day moving average price of $7.94. Autonomix Medical has a 1 year low of $2.65 and a 1 year high of $32.55.

Analyst Ratings Changes

A number of equities analysts have issued reports on AMIX shares. Zacks Research upgraded Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. Weiss Ratings lowered Autonomix Medical from a “sell (e+)” rating to a “sell (e)” rating in a report on Friday, July 10th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $42.00.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.